Theravance Biopharma (TBPH) Stock Chart & Stock Price History $10.67 +0.10 (+0.95%) Closing price 04:00 PM EasternExtended Trading$10.68 +0.01 (+0.05%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Theravance Biopharma Stock Price Performance The Theravance Biopharma (TBPH) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 21.66%, with a year-to-date return of 13.39%. In the past month, the stock has increased 14.73%, reflecting recent market activity. As of the latest close, Theravance Biopharma traded at $10.57 with a market cap of $528.50 million and volume of 142,685 shares. Five years ago, the stock traded at $22.06, representing a 51.63% decrease over that period. At the time, it had a market cap of $1.41 billion and a volume of 357,261 shares. Receive TBPH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Theravance Biopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.47%1 Month Performance+14.73%3 Month Performance+13.63%Year-To-Date Performance+13.39%1 Year Performance+21.66%5 Year Performance-51.63% TBPH Stock Chart for Tuesday, June, 24, 2025 TBPH Chart by TradingView Theravance Biopharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/24/2025$10.57$10.67+0.95%$10.77$10.55146,181 shs$533.50 million06/23/2025$10.63$10.57-0.56%$10.69$10.44142,685 shs$528.50 million06/20/2025$10.62$10.63+0.09%$10.69$10.56193,858 shs$531.50 million06/19/2025$10.62$10.62$10.72$10.53162,054 shs$531 million06/18/2025$10.60$10.62+0.19%$10.72$10.53162,054 shs$531 million06/17/2025$10.75$10.60-1.40%$11.00$10.42181,277 shs$530.01 million06/16/2025$10.69$10.75+0.56%$10.80$10.65155,522 shs$537.51 million06/13/2025$10.61$10.69+0.75%$10.73$10.46186,967 shs$534.51 million06/12/2025$10.61$10.61$10.70$10.55310,183 shs$530.51 million06/11/2025$10.73$10.61-1.12%$10.78$10.52272,170 shs$530.51 million Get the Latest News and Ratings for TBPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Theravance Biopharma and its competitors with MarketBeat's FREE daily newsletter. 06/10/2025$10.95$10.73-2.01%$11.04$10.67148,257 shs$536.51 million06/09/2025$11.25$10.95-2.67%$11.27$10.90246,154 shs$547.51 million06/06/2025$10.77$11.25+4.46%$11.50$10.81295,003 shs$562.51 million06/05/2025$11.01$10.77-2.18%$10.97$10.69261,278 shs$538.51 million06/04/2025$11.12$11.01-0.99%$11.17$10.85318,294 shs$550.51 million06/03/2025$11.15$11.12-0.27%$11.82$11.00717,216 shs$556.01 million06/02/2025$9.25$11.15+20.54%$11.21$9.981.81 million shs$557.51 million05/30/2025$9.30$9.25-0.54%$9.36$9.16200,660 shs$462.51 million05/29/2025$9.15$9.30+1.64%$9.45$9.10127,572 shs$465.01 million05/28/2025$9.28$9.15-1.40%$9.35$9.12156,274 shs$457.51 million05/27/2025$9.30$9.28-0.22%$9.47$9.22170,750 shs$464.01 million05/26/2025$9.30$9.30$9.53$9.26187,157 shs$465.01 million05/23/2025$9.49$9.30-2.00%$9.53$9.26187,157 shs$465.01 million Related Companies BCRX Stock Price Chart RXRX Stock Price Chart NAMS Stock Price Chart INDV Stock Price Chart CNTA Stock Price Chart SPRY Stock Price Chart EVO Stock Price Chart OCUL Stock Price Chart GRDN Stock Price Chart DYN Stock Price Chart Receive TBPH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Theravance Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TBPH) was last updated on 6/24/2025 by MarketBeat.com Staff From Our PartnersSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWall Street is using Bitcoin against youBitcoin is rising again, and institutions are pouring billions into Bitcoin ETFs. At first glance, that mig...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theravance Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Theravance Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
